Patents by Inventor Matthias Jöhnck

Matthias Jöhnck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10617975
    Abstract: The present invention refers to a method for the separation of peptide aggregates and fragments from solutions containing target peptide.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: April 14, 2020
    Assignee: MERCK PATENT GMBH
    Inventors: Romas Skudas, Klaus Adrian, Bianca Edelmann, Matthias Joehnck
  • Patent number: 10457720
    Abstract: The present invention refers to a method for the separation of host cell proteins (HCPs), antibody fragments and low molecular weight substances from solutions containing antibodies.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: October 29, 2019
    Assignee: Merck Patent GmbH
    Inventors: Romas Skudas, Matthias Joehnck, Bianca Edelmann, Simon Braun, Mikhail Kozlov, Matthew T. Stone, Kevin Galipeau
  • Publication number: 20180346510
    Abstract: The present invention relates to a method for an improved preparative separation of proteins, particularly monoclonal antibodies (mAB) from its associated charge variants (e. g. acidic and basic monomers), glycosylation variants, and/or soluble size variants (e. g. aggregates, monomers, ? fragments, ¾ fragments, antigen binding fragments (Fab) and crystallisable fragments (Fc).
    Type: Application
    Filed: October 28, 2016
    Publication date: December 6, 2018
    Applicant: MERCK PATENT GMBH
    Inventor: Matthias JOEHNCK
  • Publication number: 20180327447
    Abstract: Disclosed are improved preparative (>5 g/l) protein separations, which are achieved by combining salt and pH gradients for preparative protein separations in combination with the development of a preparative step elution protein separation based on data generated by combined salt-pH gradient runs.
    Type: Application
    Filed: October 28, 2016
    Publication date: November 15, 2018
    Applicant: Merck Patent GmbH
    Inventor: Matthias JOEHNCK
  • Patent number: 9975920
    Abstract: The present invention relates to the purification of target molecules like immunoglobulins from plasma. The use of a certain type of ion exchanger based on a crosslinked polyvinylether results in especially high yields of the target molecule.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: May 22, 2018
    Assignee: MERCK PATENT GMBH
    Inventors: Annika Aldinger, Achim Schwaemmle, Matthias Joehnck, Dirk Mueller, Marc Mazur
  • Publication number: 20170340989
    Abstract: The present invention refers to a method for the separation of peptide aggregates and fragments from solutions containing target peptide.
    Type: Application
    Filed: November 18, 2015
    Publication date: November 30, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: Romas SKUDAS, Klaus ADRIAN, Bianca EDELMANN, Matthias JOEHNCK
  • Publication number: 20170073394
    Abstract: The present invention refers to a method for the separation of host cell proteins (HCPs), antibody fragments and low molecular weight substances from solutions containing antibodies.
    Type: Application
    Filed: February 18, 2015
    Publication date: March 16, 2017
    Applicant: Merck Patent GmbH
    Inventors: Romas SKUDAS, Matthias JOEHNCK, Bianca EDELMANN, Simon BRAUN, Mikhail KOZLOV, Matthew T. STONE, Kevin GALIPEAU
  • Patent number: 9303098
    Abstract: The invention relates to a process for the preparation of a separating material having improved binding capacity, and to materials prepared and to the use thereof for the separation of charged or uncharged biopolymers from liquids.
    Type: Grant
    Filed: May 5, 2009
    Date of Patent: April 5, 2016
    Assignee: MERCK PATENT GMBH
    Inventor: Matthias Joehnck
  • Publication number: 20160046664
    Abstract: The present invention relates to the purification of target molecules like immunoglobulins from plasma. The use of a certain type of ion exchanger based on a crosslinked polyvinylether results in especially high yields of the target molecule.
    Type: Application
    Filed: August 10, 2015
    Publication date: February 18, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Annika ALDINGER, Achim SCHWAEMMLE, Matthias JOEHNCK, Dirk MUELLER, Marc MAZUR
  • Patent number: 8765897
    Abstract: The present invention relates to a hydrophilic crosslinked polymer, preferably in the form of porous particles, and to the preparation and use thereof. The polymer according to the invention is produced by polymerization from chain-forming hydrophilic vinyl ethers and crosslinking, preferably heterocyclic divinyl ethers.
    Type: Grant
    Filed: November 17, 2010
    Date of Patent: July 1, 2014
    Assignee: Merck Patent GmbH
    Inventors: Matthias Joehnck, Eckhard Sabrowskii
  • Publication number: 20140155565
    Abstract: The present invention relates to a hydrophilic crosslinked polymer, preferably in the form of porous particles, and to the preparation and use thereof. The polymer according to the invention is produced by polymerisation from chain-forming hydrophilic vinyl ethers and crosslinking, preferably heterocyclic divinyl ethers.
    Type: Application
    Filed: February 5, 2014
    Publication date: June 5, 2014
    Applicant: Merck Patent GmbH
    Inventors: Matthias JOEHNCK, Eckhard SABROWSKII
  • Patent number: 8735496
    Abstract: The present invention relates to a process for the production of the largest possible spherical, monodisperse polyvinylpyrrolidone (PVP) seed particles in the micron range by dispersion polymerisation. The particles obtained in this way represent novel starting materials for the production of macroporous polymer particles, which can in turn be employed in preparative and analytical chromatography for protein preparation. They can also be employed as base material for further reactions. The novel process for the polymerisation of N-vinylpyrrolidone, which is inexpensive to carry out, gives particles having optimised quantities, such as monodispersity, sphericity and particle diameter, which can be employed in further reactions and have advantageous, in particular improved, properties for use in chromatographic separation methods.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: May 27, 2014
    Assignee: Merck Patent GmbH
    Inventors: Matthias Joehnck, Daniel Scheid
  • Publication number: 20120295992
    Abstract: The invention relates to a process for the preparation of a separating material having improved binding capacity, and to materials prepared and to the use thereof for the separation of charged or uncharged biopolymers from liquids.
    Type: Application
    Filed: August 1, 2012
    Publication date: November 22, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG
    Inventor: Matthias JOEHNCK
  • Publication number: 20120053254
    Abstract: The present invention relates to a process for the production of the largest possible spherical, monodisperse polyvinylpyrrolidone (PVP) seed particles in the micron range by dispersion polymerisation. The particles obtained in this way represent novel starting materials for the production of macroporous polymer particles, which can in turn be employed in preparative and analytical chromatography for protein preparation. They can also be employed as base material for further reactions. The novel process for the polymerisation of N-vinylpyrrolidone, which is inexpensive to carry out, gives particles having optimised quantities, such as monodispersity, sphericity and particle diameter, which can be employed in further reactions and have advantageous, in particular improved, properties for use in chromatographic separation methods.
    Type: Application
    Filed: April 27, 2010
    Publication date: March 1, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Matthias Joehnck, Daniel Scheid
  • Patent number: 7951885
    Abstract: The present invention relates to a hydrophilic crosslinked polymer, preferably in the form of porous particles, and to the preparation and use thereof. The polymer according to the invention is produced by polymerisation from chain-forming hydrophilic vinyl ethers and crosslinking, preferably heterocyclic divinyl ethers.
    Type: Grant
    Filed: June 8, 2006
    Date of Patent: May 31, 2011
    Assignee: Merck Patent GmbH
    Inventors: Matthias Joehnck, Eckhard Sabrowskii
  • Publication number: 20110091727
    Abstract: The present invention relates to a hydrophilic crosslinked polymer, preferably in the form of porous particles, and to the preparation and use thereof. The polymer according to the invention is produced by polymerisation from chain-forming hydrophilic vinyl ethers and crosslinking, preferably heterocyclic divinyl ethers.
    Type: Application
    Filed: November 17, 2010
    Publication date: April 21, 2011
    Inventors: Matthias Joehnck, Eckhard Sabrowskii
  • Publication number: 20110073547
    Abstract: The invention relates to a process for the preparation of a separating material having improved binding capacity, and to materials prepared and to the use thereof for the separation of charged or uncharged biopolymers from liquids.
    Type: Application
    Filed: May 5, 2009
    Publication date: March 31, 2011
    Applicant: MERCK PATENT GESELLSCHAFT
    Inventor: Matthias Joehnck
  • Publication number: 20080210615
    Abstract: The present invention relates to a hydrophilic crosslinked polymer, preferably in the form of porous particles, and to the preparation and use thereof. The polymer according to the invention is produced by polymerisation from chain-forming hydrophilic vinyl ethers and crosslinking, preferably heterocyclic divinyl ethers.
    Type: Application
    Filed: June 8, 2006
    Publication date: September 4, 2008
    Inventors: Matthias Joehnck, Eckhard Sabrowskii
  • Publication number: 20050158209
    Abstract: A microcomponent connection system (1) having an accomodation device for plate-shaped microcomponents (7) has a connection block (2) and a lifting device (6), by means of which the microcomponent (7) and the connection block (2) can be pressed against one another. The connection block (2) has electrical and fluid line connections (8, 9) and optical line connections (16), each of which projects in a sprung or spring-mounted manner on the underside of the connection block (2). In order to connect the microcomponent (7) to the associated line connections (8, 9, 16), the microcomponent (7) is pressed by the lifting device (6) in the direction of the connection block (2) against the electrical line connections (8) or fluid line connections (9) designed as electrically conducting spring tongues or as hollow rams (10), or optical line connections (16).
    Type: Application
    Filed: February 10, 2003
    Publication date: July 21, 2005
    Applicant: Merck Patent GmbH
    Inventors: Renate Bender, Gunter Brenner, Thomas Greve, Matthias Joehnck, Bernd Stanislawski, Michael Schmelz, Sigrid Sturmfels
  • Patent number: 6838156
    Abstract: The invention relates to a method for linking two adjacent plastic work pieces (2, 3). The inventive method is characterized in that the intended contact zone (K) of at least one of the two work pieces (2) with which the latter adjoins to the other work piece (3) is at least partially subjected to a high-energy radiation to such an extent that the glass transition temperature is reduced in a marginal zone (R). The two work pieces (2, 3) are brought in the desired position relative to each other. For establishing the connection of the two work pieces (2, 3) at least the marginal zone (R) modified by the previous radiation process is heated at least in its surface area to a temperature that is higher than the glass transition temperature of the marginal zone (R) modified by the radiation process but lower than the glass transition temperature of the zones of the work pieces (2, 3) that have not been modified.
    Type: Grant
    Filed: March 29, 2000
    Date of Patent: January 4, 2005
    Assignee: Aclara Biosciences, Inc.
    Inventors: Andreas Neyer, Matthias Jöhnck